This content is from: Africa
Podcast: Adams & Adams discuss trends in anti-counterfeiting across Africa
Godfrey Budeli and Jan-Harm Swanepoel of Adams & Adams explain the latest developments in anti-counterfeiting, in the first of a three-part podcast series on IP enforcement of pharma in Africa
In the first of a three-part podcast series by Adams & Adams on the IP enforcement of pharma in Africa, experts Godfrey Budeli and Jan-Haram Swanepoel talk to Managing IP about the practical challenges associated with fighting counterfeiting on the continent.
Counterfeit goods trade remains rife in Africa. The fundamental issues experienced include a lack of proper legislative framework, weak enforcement as a result of lack of experience and limited resources. However, the experts explain how these obstacles are not insurmountable and there are legal avenues available to effectively address the proliferation of counterfeit goods on the continent.
The experts discuss the realities of trading counterfeit COVID-19 drugs and ensuring product safety, while providing advice for business leaders and consumers contemplating evolving their operations.
About Adams & Adams
Adams & Adams is an internationally recognised and leading African law firm that specialises in providing intellectual property, corporate and commercial services.
The firm is firmly rooted in Africa – with a tenacious belief in the economic growth potential and spirit of the continent. The head office in Pretoria, the capital of South Africa, provides the perfect gateway through which our partners, supported by some 700 professionals and staff, render a broad range of legal services to clients in Africa and the rest of the world.
Through its associate offices and long established networks, the firm serves a global client base throughout the African continent - in matters of intellectual property, commercial law, property and litigation.
Related content
You can find all Managing IP podcasts here.
The material on this site is for law firms, companies and other IP specialists. It is for information only. Please read our Terms and Conditions and Privacy Notice before using the site. All material subject to strictly enforced copyright laws.
© 2021 Euromoney Institutional Investor PLC. For help please see our FAQs.